These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 14535879)

  • 1. Gastric acid-suppressive therapy and community-acquired respiratory infections.
    Laheij RJ; Van Ijzendoorn MC; Janssen MJ; Jansen JB
    Aliment Pharmacol Ther; 2003 Oct; 18(8):847-51. PubMed ID: 14535879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of community-acquired pneumonia and use of gastric acid-suppressive drugs.
    Laheij RJ; Sturkenboom MC; Hassing RJ; Dieleman J; Stricker BH; Jansen JB
    JAMA; 2004 Oct; 292(16):1955-60. PubMed ID: 15507580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between gastric acid suppressants and Clostridium difficile colitis and community-acquired pneumonia: analysis using pharmacovigilance tools.
    Hauben M; Horn S; Reich L; Younus M
    Int J Infect Dis; 2007 Sep; 11(5):417-22. PubMed ID: 17336566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of acid-suppressive drugs and risk of pneumonia: a systematic review and meta-analysis.
    Eom CS; Jeon CY; Lim JW; Cho EG; Park SM; Lee KS
    CMAJ; 2011 Feb; 183(3):310-9. PubMed ID: 21173070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acid-suppressive drugs and community-acquired pneumonia.
    Rodríguez LA; Ruigómez A; Wallander MA; Johansson S
    Epidemiology; 2009 Nov; 20(6):800-6. PubMed ID: 19797970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease.
    Dial S; Delaney JA; Barkun AN; Suissa S
    JAMA; 2005 Dec; 294(23):2989-95. PubMed ID: 16414946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of community-acquired pneumonia and the use of statins, ace inhibitors and gastric acid suppressants: a population-based case-control study.
    Myles PR; Hubbard RB; McKeever TM; Pogson Z; Smith CJ; Gibson JE
    Pharmacoepidemiol Drug Saf; 2009 Apr; 18(4):269-75. PubMed ID: 19235776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proton pump inhibitors: bacterial pneumonia.
    Prescrire Int; 2012 Sep; 21(130):210-2. PubMed ID: 23016253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acid-suppressive medication use and the risk for hospital-acquired pneumonia.
    Herzig SJ; Howell MD; Ngo LH; Marcantonio ER
    JAMA; 2009 May; 301(20):2120-8. PubMed ID: 19470989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequency and time to onset of community-acquired respiratory tract infections in patients receiving esomeprazole: a retrospective analysis of patient-level data in placebo-controlled studies.
    Estborn L; Joelson S
    Aliment Pharmacol Ther; 2015 Sep; 42(5):607-13. PubMed ID: 26147295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapy with gastric acidity inhibitors increases the risk of acute gastroenteritis and community-acquired pneumonia in children.
    Canani RB; Cirillo P; Roggero P; Romano C; Malamisura B; Terrin G; Passariello A; Manguso F; Morelli L; Guarino A;
    Pediatrics; 2006 May; 117(5):e817-20. PubMed ID: 16651285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Occurrence of community-acquired respiratory tract infection in patients receiving esomeprazole: retrospective analysis of adverse events in 31 clinical trials.
    Estborn L; Joelson S
    Drug Saf; 2008; 31(7):627-36. PubMed ID: 18558796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequency of pathogen occurrence and antimicrobial susceptibility among community-acquired respiratory tract infections in the respiratory surveillance program study: microbiology from the medical office practice environment.
    Pfaller MA; Ehrhardt AF; Jones RN
    Am J Med; 2001 Dec; 111 Suppl 9A():4S-12S; discussion 36S-38S. PubMed ID: 11755437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between use of acid-suppressive drugs and risk of gastric cancer. A nested case-control study.
    Tamim H; Duranceau A; Chen LQ; Lelorier J
    Drug Saf; 2008; 31(8):675-84. PubMed ID: 18636786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acid-suppressive medication use in acute stroke and hospital-acquired pneumonia.
    Herzig SJ; Doughty C; Lahoti S; Marchina S; Sanan N; Feng W; Kumar S
    Ann Neurol; 2014 Nov; 76(5):712-8. PubMed ID: 25164323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histamine H2-Blocker and Proton Pump Inhibitor Use and the Risk of Pneumonia in Acute Stroke: A Retrospective Analysis on Susceptible Patients.
    Arai N; Nakamizo T; Ihara H; Koide T; Nakamura A; Tabuse M; Miyazaki H
    PLoS One; 2017; 12(1):e0169300. PubMed ID: 28085910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recurrent community-acquired pneumonia in patients starting acid-suppressing drugs.
    Eurich DT; Sadowski CA; Simpson SH; Marrie TJ; Majumdar SR
    Am J Med; 2010 Jan; 123(1):47-53. PubMed ID: 20102991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acid inhibition and infections outside the gastrointestinal tract.
    Vakil N
    Am J Gastroenterol; 2009 Mar; 104 Suppl 2():S17-20. PubMed ID: 19262541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Common medications that increase the risk for developing community-acquired pneumonia.
    Restrepo MI; Mortensen EM; Anzueto A
    Curr Opin Infect Dis; 2010 Apr; 23(2):145-51. PubMed ID: 20075727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Double gastric infection with Helicobacter pylori and non-Helicobacter pylori bacteria during acid-suppressive therapy: increase of pro-inflammatory cytokines and development of atrophic gastritis.
    Sanduleanu S; Jonkers D; De Bruïne A; Hameeteman W; Stockbrügger RW
    Aliment Pharmacol Ther; 2001 Aug; 15(8):1163-75. PubMed ID: 11472319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.